A plain language summary for patients explains there were no differences in safety outcomes between adalimumab-adbm and the ...

The FDA has issued a Complete Response Letter to Telix Pharmaceuticals regarding the NDA for TLX101-CDx for the imaging of gliomas.

O NE REASON that transgender medicine is such a fraught topic is that there is little evidence behind the arguments. When ...

Soft tissue regeneration company, Aroa Biosurgery, is pleased to announce a milestone in clinical evidence. There are now over 100 peer-reviewed studies describing the efficacy of the company's ...

This study aims to combine published evidence and clinical reasoning to optimally guide clinical practice. Objectives The first is to categorise and grade the evidence for each individual physical ...

A powerful clinical artificial intelligence tool developed by University ... we are providing them with the ability to reason ...

Net loss was $23.0 million for the first quarter of 2025, resulting in a basic and diluted net loss per share of $0.89. Net loss was $13.3 million for the first quarter of 2024, resulting in basic and ...

“MIMEDX’s ongoing commitment to innovation and our expanding, best-in-class body of scientific and clinical evidence will be on full display at these high-profile conferences this spring ...

Leveraging Commercial Data Infrastructure in Clinical Drug Development is the ... the ability to generate robust evidence through advanced data analytics is crucial. This approach not only ...